Dabrafenib (Tefila) daily dosage and safe dosage range instructions

Dabrafenib (Dabrafenib) is an oral BRAF inhibitor, mainly used to treat advanced or metastatic melanoma harboring BRAF V600 mutations and some BRAF mutation-related tumors. The standard recommended dose is 150 mg twice daily, for a total daily dose of 300 mg. The medicine should be swallowed whole and should not be broken, crushed or chewed. It is also recommended to take it at the same time period to maintain stable blood concentration and improve efficacy.

In actual clinical applications, the dose of dabrafenib may need to be adjusted based on patient tolerance and side effects. Common adverse reactions include fever, rash, joint pain, fatigue and abnormal heart rhythm. If a patient experiences moderate or severe side effects, doctors may consider temporarily discontinuing the drug or reducing the dose to 75 mg twice daily (total 150 mg) until symptoms subside before resuming regular dosage. A dose that is too low may reduce the efficacy, while a dose that is too high may increase the risk of toxicity, so adjustments must be made strictly under the guidance of a doctor.

Dabrafenib is mainly metabolized by the liverCYP2C8 and CYP3A4. Therefore, combined use of strong CYP3A4 inhibitors or inducers may affect blood concentration and the dose needs to be adjusted accordingly. Additionally, patients with hepatic or renal impairment may require dose adjustments to avoid drug accumulation and adverse reactions. Elderly patients and patients with weak constitutions also need to gradually adjust the dosage under monitoring to ensure medication safety.

To ensure efficacy and safety, patients should regularly review blood routine, liver and kidney function, electrolytes and electrocardiogram while taking dabrafenib, and monitor body temperature, skin conditions and joint symptoms. Once obvious intolerance or serious adverse reactions occur, you should contact your doctor immediately to adjust the dose or suspend medication. In addition, patients need to strictly abide by the twice-daily medication regimen and do not increase or decrease the dosage on their own to ensure the best therapeutic effect and reduce the risk of side effects.

Reference materials:https://www.drugs.com/